Celldex Therapeutics reported $-14342000 in EBIT for its third fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Abbvie ABBV:US $ 4071M 760M
Agenus AGEN:US $ -32593000 29.27M
Amgen AMGN:US $ 2008M 445M
Aptinyx Inc APTX:US $ -11423000 10.16M
Arena Pharmaceuticals ARNA:US $ -135301000 36.5M
Biocept BIOC:US $ -4818790 1.61M
Bristol Myers Squibb BMY:US $ 1150M 809M
Celldex Therapeutics CLDX:US $ -14342000 6.48M
Glaxosmithkline GSK:US 1.62B 850M
Immunogen IMGN:US $ 36.48M 53.21M
Nektar Therapeutics NKTR:US $ -110721000 7.67M
Newlink Genetics NLNK:US -7157000 280K
Pfizer PFE:US $ 1152M 1309M
Rigel Pharmaceuticals RIGL:US $ -13781000 3.61M
Seattle Genetics SGEN:US $ 164.99M 473.2M